Foundation Wealth Management (Pennsylvania)’s AbbVie ABBV Stock Holding History

Foundation Wealth Management (Pennsylvania)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$233K	Buy	+925	New	+$199K	0.07%	100

Other funds holding ABBV

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Foundation Wealth Management (Pennsylvania)'s ABBV Position: Q2 2026 in Review

Foundation Wealth Management (Pennsylvania) opened a new position in AbbVie (ABBV) in Q2 2026: 925 shares worth $233K. The stake represents 0.07% of the portfolio and ranks #100 among its holdings.

2,345 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Foundation Wealth Management (Pennsylvania) held 925 shares of AbbVie worth $233K as of Q2 2026.
AbbVie was a new Foundation Wealth Management (Pennsylvania) position in Q2 2026.
AbbVie made up 0.07% of Foundation Wealth Management (Pennsylvania)'s portfolio in Q2 2026, its #100 holding.
2,345 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Foundation Wealth Management (Pennsylvania)'s 13F filing for Q2 2026, filed 22 Jul 2026.